Fredun Pharmaceuticals Stock Screener | Share Price & Fundamental Analysis
FREDUN
Pharmaceuticals
Screen Fredun Pharmaceuticals share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹1536.30
▼
-31.60 (-2.02%)
Market Cap
₹796.94 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
5.15
EPS (TTM)
₹44.83
Dividend Yield
0.04%
Debt to Equity
0.88
52W High
₹1945.20
52W Low
₹645.10
Operating Margin
14.00%
Profit Margin
6.25%
Revenue (TTM)
₹144.00
EBITDA
₹21.00
Net Income
₹9.00
Total Assets
₹487.00
Total Equity
₹141.00
Fredun Pharmaceuticals Share Price History - Stock Screener Chart
Screen FREDUN historical share price movements with interactive charts. Analyze price trends and patterns.
Fredun Pharmaceuticals Company Profile - Fundamental Screener
Screen Fredun Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for FREDUN shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE194R01017
Fredun Pharmaceuticals Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen FREDUN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 487 | 308 | 257 | 187 | 162 | 141 | 105 | 79 | 56 | 43 |
| Current Assets | 428 | 257 | 216 | 153 | 130 | 109 | 73 | 52 | 35 | 28 |
| Fixed Assets | 53 | 47 | 39 | 32 | 30 | 31 | 31 | 16 | 16 | 15 |
| Liabilities | ||||||||||
| Total Liabilities | 487 | 308 | 257 | 187 | 162 | 141 | 105 | 79 | 56 | 43 |
| Current Liabilities | 18 | 19 | 21 | 45 | 32 | 14 | 13 | 14 | 8 | 7 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 141 | 122 | 96 | 68 | 43 | 41 | 39 | 22 | 7 | 4 |
| Share Capital | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 3 | 5 | 3 |
| Reserves & Surplus | 137 | 115 | 84 | 63 | 39 | 37 | 35 | 19 | 2 | 1 |
Screen FREDUN income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun |
|---|---|---|---|---|---|---|
| Revenue | 144 | 119 | 165 | 286 | 0 | 0 |
| Expenses | 123 | 103 | 150 | 251 | 0 | 0 |
| EBITDA | 21 | 17 | 15 | 35 | 0 | 0 |
| Operating Profit % | 14.00% | 14.00% | 9.00% | 12.00% | 0.00% | 0.00% |
| Depreciation | 2 | 1 | 2 | 3 | 0 | 0 |
| Interest | 8 | 7 | 8 | 14 | 0 | 0 |
| Profit Before Tax | 13 | 9 | 7 | 20 | 0 | 0 |
| Tax | 3 | 2 | 1 | 7 | 0 | 0 |
| Net Profit | 9 | 7 | 6 | 14 | 0 | 0 |
| EPS | 19.98 | 14.33 | 12.71 | 29.09 | 0.00 | 0.00 |
Fredun Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen FREDUN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | -14 | -2 | 0 | -11 | 1 | 17 | 4 | 3 | 2 |
| Investing Activities | -8 | -9 | -4 | -1 | -2 | -5 | -8 | -7 | -6 | -3 |
| Financing Activities | 6 | 25 | 8 | -1 | 14 | 4 | -8 | 3 | 4 | 1 |
| Net Cash Flow | -2 | 1 | 1 | -2 | 2 | 0 | 1 | -1 | 1 | 0 |
Screen FREDUN shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Apr | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 48.93% | 48.93% | 48.93% | 48.93% | 48.93% | 49.17% | 48.92% | 49.17% |
| FII Holding | 0.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 1.60% | 1.59% | 1.59% | 1.59% | 1.59% | 1.60% | 1.59% | 1.60% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 43.74% | 44.52% | 44.50% | 44.55% | 44.21% | 43.89% | 43.94% | 44.02% |
| Other Holding | 5.72% | 4.96% | 4.98% | 4.93% | 5.27% | 5.35% | 5.55% | 5.22% |
| Shareholder Count | 8,120 | 7,906 | 7,976 | 8,121 | 8,018 | 7,511 | 6,840 | 7,507 |
Fredun Pharmaceuticals Dividend Screener - Share Yield Analysis
Screen FREDUN dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.70 | 0.10% |
| 2023-March | ₹0.70 | 0.10% |
| 2022-March | ₹0.70 | 0.09% |
| 2021-March | ₹0.70 | 0.08% |
| 2020-March | ₹0.66 | 0.14% |
| 2019-March | ₹0.65 | 0.56% |
| 2018-March | ₹1.00 | 0.24% |
| 2017-March | ₹0.60 | 0.42% |
| 2016-March | ₹0.00 | 0.00% |
Fredun Pharmaceuticals Index Membership - Market Screener Classification
Screen FREDUN by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Fredun Pharmaceuticals Market Events Screener - Corporate Actions
Screen FREDUN market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 0.70 /share | 57.68% | ||
| Dividend | ₹ 0.70 /share | -1.22% | ||
| Dividend | ₹ 0.70 /share | 9.32% | ||
| Dividend | ₹ 0.70 /share | -21.81% | ||
| Annual General Meeting | NA | -4.13% | ||
| Annual General Meeting | NA | 8.05% | ||
| 2025-11-08 | 2025-11-08 | Quarterly Result Announcement | NA | -9.98% |
| 2025-10-22 | 2025-10-22 | Extraordinary General Meeting | NA | 27.12% |
| 2025-07-30 | 2025-07-30 | Quarterly Result Announcement | NA | 11.44% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 6.41% |
| 2025-02-04 | 2025-02-04 | Quarterly Result Announcement | NA | 3.02% |
| 2024-10-26 | 2024-10-26 | Quarterly Result Announcement | NA | -6.18% |
| 2024-01-18 | 2024-01-18 | Extraordinary General Meeting | NA | -3.94% |
Fredun Pharmaceuticals Competitors Screener - Peer Comparison
Screen FREDUN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 416,501 | 40.16 | 54,729 | 9.71% | 10,980 | 46.18 |
| Divis Laboratories | 173,869 | 69.16 | 9,712 | 18.67% | 2,191 | 53.62 |
| Torrent Pharmaceuticals | 129,757 | 60.40 | 11,539 | 6.99% | 1,911 | 62.04 |
| Cipla | 120,727 | 22.30 | 28,410 | 7.12% | 5,291 | 44.91 |
| Dr Reddys Laboratories | 105,529 | 18.66 | 33,741 | 16.73% | 5,725 | 60.09 |
| Lupin | 96,266 | 22.21 | 22,910 | 13.74% | 3,306 | 60.88 |
| Zydus Life Science | 92,523 | 18.57 | 23,511 | 18.55% | 4,615 | 47.29 |
| Mankind Pharma | 91,364 | 51.90 | 12,744 | 20.90% | 2,007 | 53.62 |
| Aurobindo Pharma | 70,678 | 20.66 | 32,346 | 9.43% | 3,484 | 57.50 |
| Alkem Laboratories | 66,179 | 27.75 | 13,458 | 3.70% | 2,216 | 47.48 |
Fredun Pharmaceuticals Company Announcements - News Screener
Screen FREDUN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-02 | Corrigendum Through General Announcement Regarding Disclosure Of Pre-Preferential Shareholding Of Proposed Allottees Ultimate Beneficial Owners (Ubos) Revised Issue Size Of Proposed Preferential Allotment Revised List Of Allottees And Bifurcation And Brie | View |
| 2026-01-01 | Corrigendum Through General Announcement Regarding Disclosure Of Pre-Preferential Shareholding Of Proposed Allottees Ultimate Beneficial Owners (Ubos) Revised Issue Size Of Proposed Preferential Allotment Revised List Of Allottees And Bifurcation And Brie | View |
| 2026-01-01 | Intimation Of Outcome Of Analysts/Investors Meeting Under The SEBI (Listing Obligations And Disclosures Requirements) Regulation 2015 | View |
| 2025-12-11 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-29 | Corrigendum Through General Announcement Regarding Disclosure Of Ultimate Beneficial Owners (Ubos) Pre -Preferential Shareholding Of Proposed Allottees And Bifurcation And Brief Description Of The Object In Connection With The Extra-Ordinary General Meeti | View |
| 2025-11-28 | Appointment of Company Secretary and Compliance Officer | View |
| 2025-11-28 | Announcement under Regulation 30 (LODR)-Change in Directorate | View |
| 2025-11-28 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-11-15 | General Announcement Pertaining To Disclosure Of Ultimate Beneficial Owners (Ubos) Of Proposed Allottees In Connection With The Extra-Ordinary General Meeting (EGM) Held On October 22 2025. | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-12 | Audio Recording Of The Q2 FY26 Earnings Conference Call | View |
| 2025-11-11 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-10 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-09 | Revised Outcome Of Board Meeting | View |
| 2025-11-08 | Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer | View |
| 2025-11-08 | Outcome Of Board Meeting | View |
| 2025-11-08 | Board Meeting Outcome for Outcome Of Board Meeting. | View |
| 2025-11-06 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-10-28 | Board Meeting Intimation for Prior Intimation For The Board Meeting Of The Company To Be Held On Saturday 08Th November 2025 | View |
| 2025-10-22 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |